Cognitive impairment in patients with melanoma before adjuvant immune checkpoint inhibitor therapy and associations with brain gray matter, <i>catechol‐O‐methyltransferase</i> genotype, and psychological factors
These findings underscore the need for comprehensive assessments in MMPs to better understand and address CRCI. A multifaceted approach would provide valuable insights that could inform future interventions and improve patient outcomes and quality of life.
Authors
- Lisa M. Wu (ORCID: https://orcid.org/0000-0003-2241-9905)
- Jeffrey Scott Wefel (ORCID: https://orcid.org/0000-0003-3584-023X)
- Ali Amidi (ORCID: https://orcid.org/0000-0003-2921-9797)
- Jesper Folsted Kallehauge (ORCID: https://orcid.org/0000-0003-3705-5390)
- Robert Zachariae (ORCID: https://orcid.org/0000-0001-9076-3068)
- Henrik Schmidt (ORCID: https://orcid.org/0000-0002-4063-3561)
- Josefine T. Danielsen (ORCID: https://orcid.org/0000-0002-8249-9700)
- Julie Kofoed Thomadsen
Institutions
- Reykjavík University (IS)
- The University of Texas MD Anderson Cancer Center (US)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Cancer
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1002/cncr.35683
- Citations
- 1
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Aarhus Universitetshospital
- Aase og Ejnar Danielsens Fond
- Fabrikant Einar Willumsens Mindelegat